Merrimack Pharma (MACK) Tops Q2 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Merrimack Pharma (MACK) Tops Q2 EPS by 10c

Mizuho Securities Reiterates Bullish Stance on Merrimack Pharmaceuticals (MACK) Into MM-398 PDUFA Date

August 11, 2015 7:46 AM EDT

Mizuho Securities analyst Peter Lawson reiterated an Outperform rating and $16 price target on Merrimack Pharmaceuticals (NASDAQ: MACK) heading into an October 24 PDUFA date for MM-398.

"The company remains one of our favorite biotech plays and we feel it is overlooked by investors, given... More